evenfolioETF Details
Defiance ETFs LLC·Health·ASD · Nasdaq
Defiance Autism Impact ETF (ASD)
- Price
- $27.51
- —12 Nov 2026
- Assets
- $1.4M
- Total net assets
- Expense ratio
- 0.79%
- Category 1.00%
- Yield
- —
- Trailing distributions
- 1Y return
- —
- Category 23.8%
- 3Y CAGR
- —
- Category 20.2%
- 5Y CAGR
- —
- Category 3.9%
$27.51—12 Nov 2026
Fund
- Assets
- $1.4M
- Expense
- 0.79%
- Categ. exp
- 1.00%
- Yield
- —
ReturnFundCateg.
1Y—23.8%
3Y—20.2%
5Y—3.9%
Launch11.8%—
Loading NAV history…
Defiance Autism Impact ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +4.4% | -0.9% | — | — | — | — | — | — | +11.8% |
| Health average | 6.4% | 4.0% | 21.1% | 20.0% | 23.8% | 20.2% | 3.9% | 10.1% | 11.2% |
| Difference | -2.0% | -4.9% | — | — | — | — | — | — | +0.6% |
Holdings
The 10 largest positions make up 28.7% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| RVTY | Revvity Inc | 3.34% |
| RGEN | Repligen Corp | 3.11% |
| TEVA.TA | Teva Pharmaceutical Industries Ltd | 2.88% |
| MCOV-B.ST | Medicover AB Class B | 2.82% |
| 4506.T | Sumitomo Pharma Co Ltd | 2.79% |
| LLY | Eli Lilly and Co | 2.77% |
| 4578.T | Otsuka Holdings Co Ltd | 2.76% |
| 4502.T | Takeda Pharmaceutical Co Ltd | 2.75% |
| NOVN.SW | Novartis AG Registered Shares | 2.73% |
| PFE | Pfizer Inc | 2.72% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 20.1
- P/B
- 2.6
- P/S
- 2.2
- P/CF
- 13.2
Sector allocation
Share of the equity the fund holds.
- Health care86.7%
- Consumer staples5.2%
- Communication services2.7%
- Industrials2.7%
- Consumer discretionary2.6%
Asset mix
- Stocks99.3%
- Cash0.6%
- Other0.1%
ETF details
- Issuer
- Defiance ETFs LLC
- Category
- Equity · Health
- Ticker
- ASD
- Exchange
- Nasdaq
- Inception
- 1 Jun 2026 (0.4 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.79% (category 1.00%)
- Holdings turnover
- 0% (category 51%)
- Distribution yield
- —
- Beta, 3 years
- 0.00
- Total net assets
- $1.4M
Prices and returns as of 12 Nov 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- GNMX · Corgi Genomics & Precision Medicine ETFCorgi Funds · $1.3M · ER 0.35%
- GSKH · GSK plc ADRhedgedADRH · $700,000 · ER 0.19%
- TRUH · VanEck Healthcare TruSector ETFVanEck · $640,000 · ER 0.10%
- XLV · State Street Health Care Select Sector SPDR ETFState Street Investment Management · $49.1B · ER 0.08%5Y 8.8%
- VHT · Vanguard Health Care ETFVanguard · $21.8B · ER 0.09%5Y 7.6%
- IBB · iShares Biotechnology ETFiShares · $11.5B · ER 0.44%5Y 7.0%

